1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
RESIDUE PRO 13 IS A CIS PROLINE.
Guntert, P.
Williamson, M.P.
Havel, T.F.
Wuthrich, K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H7 N O3
129.114
n
PYROGLUTAMIC ACID
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
182
295
315
10.1016/0022-2836(85)90347-X
3839023
Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry.
1985
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
173
341
Secondary Structure in the Solution Conformation of the Proteinase Inhibitor IIA from Bull Seminal Plasma by Nuclear Magnetic Resonance
1984
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
166
641
Assignment of the 1H Nuclear Magnetic Resonance Spectrum of the Proteinase Inhibitor IIA from Bull Seminal Plasma by Two-Dimensional Nuclear Magnetic Resonance at 500 Mhz
1983
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
166
631
Characterization of the Proteinase Inhibitor IIA from Bull Seminal Plasma by 1H Nuclear Magnetic Resonance. Stability, Amide Proton Exchange and Mobility of Aromatic Residues
1983
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6191.089
PROTEINASE INHIBITOR IIA
1
man
polymer
no
yes
(PCA)GAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC
QGAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
sample
9913
Bos taurus
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
entity_poly
pdbx_struct_mod_residue
struct_conn
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
Derived calculations
Polymer sequence
1
0
1991-04-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
2
0
2019-12-25
_pdbx_database_status.process_site
_entity_poly.pdbx_seq_one_letter_code_can
_pdbx_struct_mod_residue.parent_comp_id
_struct_conn.pdbx_leaving_atom_flag
Y
BNL
1990-05-14
REL
REL
5
PCA
1
n
1
PCA
1
A
GLY
2
n
2
GLY
2
A
ALA
3
n
3
ALA
3
A
GLN
4
n
4
GLN
4
A
VAL
5
n
5
VAL
5
A
ASP
6
n
6
ASP
6
A
CYS
7
n
7
CYS
7
A
ALA
8
n
8
ALA
8
A
GLU
9
n
9
GLU
9
A
PHE
10
n
10
PHE
10
A
LYS
11
n
11
LYS
11
A
ASP
12
n
12
ASP
12
A
PRO
13
n
13
PRO
13
A
LYS
14
n
14
LYS
14
A
VAL
15
n
15
VAL
15
A
TYR
16
n
16
TYR
16
A
CYS
17
n
17
CYS
17
A
THR
18
n
18
THR
18
A
ARG
19
n
19
ARG
19
A
GLU
20
n
20
GLU
20
A
SER
21
n
21
SER
21
A
ASN
22
n
22
ASN
22
A
PRO
23
n
23
PRO
23
A
HIS
24
n
24
HIS
24
A
CYS
25
n
25
CYS
25
A
GLY
26
n
26
GLY
26
A
SER
27
n
27
SER
27
A
ASN
28
n
28
ASN
28
A
GLY
29
n
29
GLY
29
A
GLU
30
n
30
GLU
30
A
THR
31
n
31
THR
31
A
TYR
32
n
32
TYR
32
A
GLY
33
n
33
GLY
33
A
ASN
34
n
34
ASN
34
A
LYS
35
n
35
LYS
35
A
CYS
36
n
36
CYS
36
A
ALA
37
n
37
ALA
37
A
PHE
38
n
38
PHE
38
A
CYS
39
n
39
CYS
39
A
LYS
40
n
40
LYS
40
A
ALA
41
n
41
ALA
41
A
VAL
42
n
42
VAL
42
A
MET
43
n
43
MET
43
A
LYS
44
n
44
LYS
44
A
SER
45
n
45
SER
45
A
GLY
46
n
46
GLY
46
A
GLY
47
n
47
GLY
47
A
LYS
48
n
48
LYS
48
A
ILE
49
n
49
ILE
49
A
ASN
50
n
50
ASN
50
A
LEU
51
n
51
LEU
51
A
LYS
52
n
52
LYS
52
A
HIS
53
n
53
HIS
53
A
ARG
54
n
54
ARG
54
A
GLY
55
n
55
GLY
55
A
LYS
56
n
56
LYS
56
A
CYS
57
n
57
CYS
57
A
author_defined_assembly
1
monomeric
A
PCA
1
PYROGLUTAMIC ACID
A
PCA
1
GLN
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
3
A
A
NH1
OXT
ARG
CYS
54
57
1.99
1
A
ARG
19
0.266
SIDE CHAIN
1
A
HIS
24
0.109
SIDE CHAIN
1
A
HIS
53
0.217
SIDE CHAIN
1
A
ARG
54
0.201
SIDE CHAIN
2
A
ARG
19
0.253
SIDE CHAIN
2
A
HIS
24
0.173
SIDE CHAIN
2
A
ARG
54
0.302
SIDE CHAIN
3
A
HIS
53
0.161
SIDE CHAIN
3
A
ARG
54
0.272
SIDE CHAIN
4
A
ARG
19
0.206
SIDE CHAIN
4
A
ARG
54
0.295
SIDE CHAIN
5
A
ARG
19
0.152
SIDE CHAIN
5
A
ARG
54
0.301
SIDE CHAIN
1
-11.55
1.80
110.60
99.05
A
A
A
N
CA
CB
TYR
TYR
TYR
16
16
16
N
1
6.89
1.10
114.20
121.09
A
A
A
CA
CB
SG
CYS
CYS
CYS
17
17
17
N
1
-4.09
0.60
121.00
116.91
A
A
A
CB
CG
CD2
TYR
TYR
TYR
32
32
32
N
1
3.74
0.60
121.00
124.74
A
A
A
CB
CG
CD1
TYR
TYR
TYR
32
32
32
N
1
11.65
1.50
110.80
122.45
A
A
A
N
CA
CB
CYS
CYS
CYS
36
36
36
N
2
-4.30
0.70
120.80
116.50
A
A
A
CB
CG
CD1
PHE
PHE
PHE
10
10
10
N
2
-17.00
1.90
110.10
93.10
A
A
A
CB
CA
C
SER
SER
SER
27
27
27
N
2
18.61
2.70
111.00
129.61
A
A
A
N
CA
C
ASN
ASN
ASN
50
50
50
N
3
-16.58
1.90
110.10
93.52
A
A
A
CB
CA
C
SER
SER
SER
27
27
27
N
3
14.01
1.50
110.50
124.51
A
A
A
N
CA
CB
SER
SER
SER
27
27
27
N
3
15.11
2.10
120.10
135.21
A
A
A
CA
C
O
SER
SER
SER
27
27
27
N
3
-14.45
2.20
117.20
102.75
A
A
A
CA
C
N
SER
SER
ASN
27
27
28
Y
2
A
A
CA
CB
SER
SER
27
27
0.098
0.015
1.525
1.623
N
3
A
A
CA
CB
SER
SER
27
27
0.098
0.015
1.525
1.623
N
1
A
GLN
4
-97.84
52.43
1
A
VAL
5
-102.34
40.41
1
A
LYS
11
-65.03
-74.67
1
A
VAL
15
-109.20
-86.89
1
A
THR
18
51.49
-82.46
1
A
ASN
22
170.15
103.45
1
A
PRO
23
-69.88
94.81
1
A
SER
27
-48.23
-79.98
1
A
ASN
28
-147.74
33.60
1
A
TYR
32
-154.76
-141.92
1
A
LYS
44
-90.49
51.71
1
A
LYS
48
-147.45
21.88
1
A
HIS
53
-47.15
-11.02
2
A
ALA
3
71.28
-86.98
2
A
GLN
4
75.56
-5.91
2
A
CYS
7
-108.62
47.62
2
A
LYS
11
-94.11
47.97
2
A
ASP
12
-42.63
160.93
2
A
LYS
14
171.03
-36.94
2
A
THR
18
-124.20
-85.35
2
A
ARG
19
-128.46
-155.81
2
A
ASN
22
70.17
129.54
2
A
SER
27
-114.85
-163.38
2
A
CYS
36
-62.36
-71.04
2
A
MET
43
-55.76
-78.18
2
A
LYS
44
-91.47
53.36
2
A
SER
45
-75.06
-74.01
2
A
LYS
48
-172.67
124.58
2
A
LYS
52
-106.50
-96.00
3
A
ALA
3
-174.94
62.05
3
A
ASP
6
-159.23
82.95
3
A
THR
18
-83.52
-75.40
3
A
ARG
19
-100.14
63.24
3
A
GLU
20
-46.85
171.44
3
A
SER
21
-101.95
74.89
3
A
ASN
22
-41.38
171.31
3
A
PRO
23
5.04
92.08
3
A
CYS
25
-64.86
-172.96
3
A
ASN
28
-162.81
-54.72
3
A
LYS
48
178.57
146.27
3
A
LEU
51
48.37
109.92
3
A
ARG
54
-44.29
165.11
4
A
ALA
3
75.35
-1.25
4
A
GLN
4
47.21
-165.92
4
A
CYS
7
-123.93
-57.86
4
A
LYS
11
-79.07
-87.86
4
A
PRO
13
-104.53
-60.91
4
A
VAL
15
29.78
91.85
4
A
CYS
17
-152.86
61.34
4
A
THR
18
-165.29
42.18
4
A
SER
21
-148.91
41.03
4
A
SER
27
-43.10
-85.63
4
A
ASN
28
-140.57
30.60
4
A
GLU
30
-160.24
-160.18
4
A
LYS
44
-87.29
-78.26
4
A
SER
45
26.75
36.16
4
A
LEU
51
-54.10
-179.09
4
A
LYS
52
163.16
108.77
4
A
HIS
53
-48.36
-130.53
5
A
ALA
3
59.23
174.46
5
A
CYS
7
-106.54
-67.93
5
A
LYS
11
-90.48
36.62
5
A
ASP
12
-44.69
-74.96
5
A
PRO
13
-103.64
-135.86
5
A
LYS
14
104.58
43.21
5
A
ARG
19
-142.10
-115.24
5
A
SER
21
-145.15
38.45
5
A
ASN
22
49.14
143.37
5
A
ASN
28
-160.63
-53.40
5
A
SER
45
27.58
-81.42
5
A
LYS
48
74.72
104.22
5
A
ILE
49
-142.12
51.95
5
A
LYS
52
-151.48
-81.05
PROTEINASE INHIBITOR IIA (BUSI IIA) (NMR, 5 DISTANCE CONSTRAINED STRUCTURES)
SOLUTION CONFORMATION OF PROTEINASE INHIBITOR IIA FROM BULL SEMINAL PLASMA BY 1H NUCLEAR MAGNETIC RESONANCE AND DISTANCE GEOMETRY
1
Y
N
A
ASN
34
A
ASN
34
HELX_P
ALPHA HELIX
A
SER
45
A
SER
45
1
H1
12
disulf
2.110
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
39
A
SG
CYS
39
1_555
disulf
1.990
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
36
A
SG
CYS
36
1_555
disulf
1.973
A
CYS
25
A
SG
CYS
25
1_555
A
CYS
57
A
SG
CYS
57
1_555
covale
1.326
both
A
PCA
1
A
C
PCA
1
1_555
A
GLY
2
A
N
GLY
2
1_555
PROTEINASE INHIBITOR
PROTEINASE INHIBITOR
A
ASP
12
A
ASP
12
1
A
PRO
13
A
PRO
13
-0.02
A
ASP
12
A
ASP
12
2
A
PRO
13
A
PRO
13
0.12
A
ASP
12
A
ASP
12
3
A
PRO
13
A
PRO
13
-0.02
A
ASP
12
A
ASP
12
4
A
PRO
13
A
PRO
13
0.22
A
ASP
12
A
ASP
12
5
A
PRO
13
A
PRO
13
0.02
IAC2_BOVIN
UNP
1
1
P01001
QGAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC
2
57
1BUS
2
57
P01001
A
1
2
57
3
anti-parallel
anti-parallel
A
GLY
29
A
GLY
29
A
GLY
33
A
GLY
33
A
PRO
23
A
PRO
23
A
SER
27
A
SER
27
A
ASN
50
A
ASN
50
A
GLY
55
A
GLY
55
1
P 1